Of these 141 patients, 98 had ER-positive (HER2-negative) disease, 15 had HER2-positive (ER-positive or negative) disease, and 25 were diagnosed with triple-negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.